Close

Bristol-Myers Squibb (BMY): Opdivo/Yervoy Optionality Removed - Jefferies

January 20, 2017 8:02 AM EST Send to a Friend
Jefferies analyst, Jeffrey Holford, reiterated his Buy rating on shares of Bristol-Myers Squibb Co. (NYSE: BMY) after Bristol-Myers' management confirmed ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login